Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126595691 | 12659569 | 1 | I | 20160811 | 20160815 | 20160817 | 20160817 | EXP | US-PFIZER INC-2016388447 | PFIZER | 92.00 | YR | F | Y | 0.00000 | 20160817 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126595691 | 12659569 | 1 | PS | DETROL LA | TOLTERODINE TARTRATE | 1 | Oral | 4 MG, 1X/DAY | 21228 | 4 | MG | MODIFIED-RELEASE CAPSULE, SOFT | QD | ||||||
| 126595691 | 12659569 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, 1X/DAY | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||||
| 126595691 | 12659569 | 3 | C | OXYCODONE | OXYCODONE | 1 | Oral | 5 MG, AS NEEDED; ONE, EVERY 6 HOURS AS NEEDED | 0 | 5 | MG | TABLET | |||||||
| 126595691 | 12659569 | 4 | C | LEVALBUTEROL. | LEVALBUTEROL | 1 | Nasal | 1.25 MG, AS NEEDED; SOLUTION NEBULIZER EVERY 3 HOURS AS NEEDED | 0 | 1.25 | MG | NEBULISER SOLUTION | |||||||
| 126595691 | 12659569 | 5 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 125 UG, 1X/DAY | 0 | 125 | UG | TABLET | QD | ||||||
| 126595691 | 12659569 | 6 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 6.25 MG, 2X/DAY; WITH FOOD TWICE A DAY | 0 | 6.25 | MG | TABLET | BID | ||||||
| 126595691 | 12659569 | 7 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 2 DF, 2X/DAY; 160-4.5MCG 2 PUFFS TWICE A DAY | 0 | 2 | DF | BID | |||||||
| 126595691 | 12659569 | 8 | C | DONEPEZIL HCL | DONEPEZIL HYDROCHLORIDE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | ||||||
| 126595691 | 12659569 | 9 | C | LOSARTAN K | LOSARTAN POTASSIUM | 1 | Oral | 25 MG, 1X/DAY | 0 | 25 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126595691 | 12659569 | 3 | Pain |
| 126595691 | 12659569 | 4 | Lung disorder |
| 126595691 | 12659569 | 6 | Hypertension |
| 126595691 | 12659569 | 7 | Lung disorder |
| 126595691 | 12659569 | 8 | Hypertension |
| 126595691 | 12659569 | 9 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126595691 | 12659569 | OT |
| 126595691 | 12659569 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126595691 | 12659569 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |